Perampanel Monotherapy in Epilepsy Patients with Focal and Generalized Seizures
Latest Information Update: 03 Jun 2021
Price :
$35 *
At a glance
- Drugs Perampanel (Primary)
- Indications Generalised seizures; Seizures
- Focus Adverse reactions; Therapeutic Use
- 22 Apr 2021 Results assessing real-world effectiveness, safety and tolerability of perampanel (PER) when used as monotherapy in everyday clinical practice presented at the 73rd Annual Meeting of the American Academy of Neurology
- 25 Jan 2021 New trial record
- 08 Dec 2020 Results (n=102) presented at the 74th Annual Meeting of the American Epilepsy Society